- Home
- OLMA vs RM Comparison
OLMA vs RM Comparison
Compare OLMA & RM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- RM
- Stock Information
- Founded
- OLMA 2006
- RM 1987
- Country
- OLMA United States
- RM United States
- Employees
- OLMA N/A
- RM N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- RM Finance: Consumer Services
- Sector
- OLMA Health Care
- RM Finance
- Exchange
- OLMA Nasdaq
- RM Nasdaq
- Market Cap
- OLMA 289.0M
- RM 298.3M
- IPO Year
- OLMA 2020
- RM 2012
- Fundamental
- Price
- OLMA $4.67
- RM $28.99
- Analyst Decision
- OLMA Strong Buy
- RM Hold
- Analyst Count
- OLMA 3
- RM 3
- Target Price
- OLMA $27.67
- RM $30.00
- AVG Volume (30 Days)
- OLMA 902.4K
- RM 49.4K
- Earning Date
- OLMA 05-16-2025
- RM 04-30-2025
- Dividend Yield
- OLMA N/A
- RM 4.12%
- EPS Growth
- OLMA N/A
- RM 41.13
- EPS
- OLMA N/A
- RM 3.29
- Revenue
- OLMA N/A
- RM $577,647,000.00
- Revenue This Year
- OLMA N/A
- RM $14.45
- Revenue Next Year
- OLMA N/A
- RM $8.95
- P/E Ratio
- OLMA N/A
- RM $8.84
- Revenue Growth
- OLMA N/A
- RM 6.45
- 52 Week Low
- OLMA $2.86
- RM $25.41
- 52 Week High
- OLMA $16.62
- RM $37.52
- Technical
- Relative Strength Index (RSI)
- OLMA 50.50
- RM 42.28
- Support Level
- OLMA $4.35
- RM $26.18
- Resistance Level
- OLMA $5.74
- RM $29.48
- Average True Range (ATR)
- OLMA 0.40
- RM 1.51
- MACD
- OLMA -0.02
- RM -0.40
- Stochastic Oscillator
- OLMA 25.26
- RM 35.55
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About RM Regional Management Corp.
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.